FR2870125B1 - Formulation du type spot-on utile en cosmetologie et en dermatologie - Google Patents

Formulation du type spot-on utile en cosmetologie et en dermatologie

Info

Publication number
FR2870125B1
FR2870125B1 FR0405136A FR0405136A FR2870125B1 FR 2870125 B1 FR2870125 B1 FR 2870125B1 FR 0405136 A FR0405136 A FR 0405136A FR 0405136 A FR0405136 A FR 0405136A FR 2870125 B1 FR2870125 B1 FR 2870125B1
Authority
FR
France
Prior art keywords
cosmetology
dermatology
formulation
spot
type useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0405136A
Other languages
English (en)
Other versions
FR2870125A1 (fr
Inventor
Jean Claude Allart
Jean Marie Lefevre
Jacques Peyrot
Jean Paul Marty
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dermaconcept JMC SARL
Original Assignee
Dermaconcept JMC SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0405136A priority Critical patent/FR2870125B1/fr
Application filed by Dermaconcept JMC SARL filed Critical Dermaconcept JMC SARL
Priority to EP05770872A priority patent/EP1748758A1/fr
Priority to BRPI0510806-3A priority patent/BRPI0510806A/pt
Priority to KR1020067026165A priority patent/KR20070026580A/ko
Priority to JP2007512289A priority patent/JP2007537214A/ja
Priority to PCT/FR2005/001188 priority patent/WO2005115335A1/fr
Priority to CA002562565A priority patent/CA2562565A1/fr
Priority to US11/596,334 priority patent/US20090010968A1/en
Publication of FR2870125A1 publication Critical patent/FR2870125A1/fr
Priority to IL178889A priority patent/IL178889A0/en
Application granted granted Critical
Publication of FR2870125B1 publication Critical patent/FR2870125B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR0405136A 2004-05-12 2004-05-12 Formulation du type spot-on utile en cosmetologie et en dermatologie Expired - Fee Related FR2870125B1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR0405136A FR2870125B1 (fr) 2004-05-12 2004-05-12 Formulation du type spot-on utile en cosmetologie et en dermatologie
BRPI0510806-3A BRPI0510806A (pt) 2004-05-12 2005-05-12 formulação do tipo spot-on para a aplicação tópica localizada, utilização de um princìpio ativo e método tratamento cosmético da pele
KR1020067026165A KR20070026580A (ko) 2004-05-12 2005-05-12 화장용 및 피부용으로 유용한 스팟온 제제
JP2007512289A JP2007537214A (ja) 2004-05-12 2005-05-12 美容術及び皮膚科医学において有用なスポット適用配合物
EP05770872A EP1748758A1 (fr) 2004-05-12 2005-05-12 Formulation de type spot-on utile en cosmetologie et en dermatologie
PCT/FR2005/001188 WO2005115335A1 (fr) 2004-05-12 2005-05-12 Formulation de type spot-on utile en cosmetologie et en dermatologie
CA002562565A CA2562565A1 (fr) 2004-05-12 2005-05-12 Formulation de type spot-on utile en cosmetologie et en dermatologie
US11/596,334 US20090010968A1 (en) 2004-05-12 2005-05-12 Spot-on formulation useful for cosmetology and dermatology
IL178889A IL178889A0 (en) 2004-05-12 2006-10-26 Spot-on formulation useful for cosmetology and dermatology

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0405136A FR2870125B1 (fr) 2004-05-12 2004-05-12 Formulation du type spot-on utile en cosmetologie et en dermatologie

Publications (2)

Publication Number Publication Date
FR2870125A1 FR2870125A1 (fr) 2005-11-18
FR2870125B1 true FR2870125B1 (fr) 2010-03-26

Family

ID=34948685

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0405136A Expired - Fee Related FR2870125B1 (fr) 2004-05-12 2004-05-12 Formulation du type spot-on utile en cosmetologie et en dermatologie

Country Status (9)

Country Link
US (1) US20090010968A1 (fr)
EP (1) EP1748758A1 (fr)
JP (1) JP2007537214A (fr)
KR (1) KR20070026580A (fr)
BR (1) BRPI0510806A (fr)
CA (1) CA2562565A1 (fr)
FR (1) FR2870125B1 (fr)
IL (1) IL178889A0 (fr)
WO (1) WO2005115335A1 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2389630T3 (es) * 2004-11-10 2012-10-29 Hisamitsu Pharmaceutical Co., Inc. Fármacos para uso externo y parche adhesivo
KR101003532B1 (ko) 2008-08-06 2010-12-28 (주)다미화학 탈모의 예방, 치료, 또는 육모용 조성물
US10022348B2 (en) 2009-05-20 2018-07-17 Sun Pharmaceutical Industries Limited Topical solution of isotretinoin
MX2011012233A (es) 2009-05-20 2012-04-19 Ranbaxy Lab Ltd Soluciones de retinoide topicas.
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
PT2782584T (pt) 2011-11-23 2021-09-02 Therapeuticsmd Inc Preparações e terapias de substituição para hormonoterapias naturais combinadas
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
JP2017516768A (ja) 2014-05-22 2017-06-22 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 天然の併用ホルモン補充療法剤及び療法
US10098894B2 (en) 2014-07-29 2018-10-16 Therapeuticsmd, Inc. Transdermal cream
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
KR102644587B1 (ko) 2015-12-24 2024-03-07 (주)아모레퍼시픽 유사 세라마이드 화합물 및 그 제조방법
WO2017111387A1 (fr) * 2015-12-24 2017-06-29 (주)아모레퍼시픽 Composé pseudo-céramide et son procédé de préparation
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
WO2019002367A1 (fr) * 2017-06-28 2019-01-03 Spherium Biomed, S.L. Compositions topiques pour le traitement de maladies dermatologiques
CN107714937A (zh) * 2017-12-12 2018-02-23 青岛大学附属医院 一种用于治疗皮脂缺乏症的中药冲剂及其制备方法
AU2019230097B2 (en) * 2018-03-09 2021-10-28 Ocusoft, Inc. Topical skin care compositions
KR102592150B1 (ko) * 2020-07-09 2023-10-20 크로다코리아 주식회사 살리실산 유도체를 포함하는 신규한 스핑고지질 및 이를 포함하는 조성물

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU78168A1 (fr) * 1977-09-22 1979-05-25 F Genieyz Composition de traitement de la peau et procede de preparation
US4612194A (en) * 1984-02-15 1986-09-16 Roshdy Ismail Anti-rheumatic agents and their use
JPH01110610A (ja) * 1987-10-22 1989-04-27 Lion Corp ニキビ予防剤
IE62871B1 (en) * 1988-03-08 1995-03-08 Warner Lambert Co Compositions with enhanced penetration
US4892737A (en) * 1988-09-22 1990-01-09 University Of Florida Composition and method for enhancing permeability of topical drugs
DE4113346A1 (de) * 1991-04-24 1992-10-29 Lang Erich Zubereitung zur kraeftigung und regeneration des haarwuchses
DE4407742C1 (de) * 1994-03-08 1995-06-22 Hexal Pharma Gmbh Transdermales System in Form eines Pflasters mit einem Tamoxifen-Derivat
US6426333B1 (en) * 1996-09-19 2002-07-30 Merial Spot-on formulations for combating parasites
US6008254A (en) * 1997-05-09 1999-12-28 Kligman; Douglas E. Method of treating skin disorders with high-strength tretinoin
US6057384A (en) * 1997-10-31 2000-05-02 Hewlett-Packard Company Latex polymer blends for improving the permanence of ink-jet inks
FR2795960B1 (fr) * 1999-07-05 2001-10-19 Sanofi Elf Microemulsions stables pour l'administration d'acides gras a l'homme ou a l'animal, et utilisation de ces microemulsions
US6361806B1 (en) * 2000-02-23 2002-03-26 Michael P. Allen Composition for and method of topical administration to effect changes in subcutaneous adipose tissue
US6365138B1 (en) * 2000-04-07 2002-04-02 The Regents Of The University Of California Compositions for metabolic protection and repair of lips
WO2004064841A1 (fr) * 2003-01-23 2004-08-05 Shire Holdings Ag Formulation et methodes de traitement de la thrombocythemie

Also Published As

Publication number Publication date
EP1748758A1 (fr) 2007-02-07
WO2005115335A1 (fr) 2005-12-08
US20090010968A1 (en) 2009-01-08
BRPI0510806A (pt) 2007-11-06
JP2007537214A (ja) 2007-12-20
IL178889A0 (en) 2007-03-08
KR20070026580A (ko) 2007-03-08
FR2870125A1 (fr) 2005-11-18
CA2562565A1 (fr) 2005-12-08

Similar Documents

Publication Publication Date Title
FR2870125B1 (fr) Formulation du type spot-on utile en cosmetologie et en dermatologie
DK3366283T3 (da) Direkte sammenpresningsformulering og fremgangsmåde
DK1480615T3 (da) Superfin formoterolformulering
BRPI0820899A2 (pt) Formulação cosmética, e, uso da composição
ATE382261T1 (de) Flüssige formulierung
JP2006502186A5 (ja) β-グルカンの使用
BRPI0608260A2 (pt) preparações cosméticas e dermatológicas
FR2870739B1 (fr) Utilisation du lif en cosmetique et en dermatologie
ITMI20040198A1 (it) Dispositivo reattore-rigeneratore e suo impiego nella produzione di stirene
DK1928235T3 (da) Præparat og fremgangsmåde til anvendelse i brusk-sygdoms-tilstande
FR2896154B1 (fr) Composition cosmetique ou dermatologique et son utilisation
BRPI0615630A2 (pt) composição farmacêutica, e, uso de sertindol
DK1933840T3 (da) Anvendelse af delmopinol i behandlingen af acne
ITMI20051273A1 (it) Composizioni in forma di lipogel per uso cosmetico detergente e farmaceutico
ITMI20051417A1 (it) Formulazione topica in forma di gel contenente come ingredienti attivi ciclovit e lidocaina
DE602004000627D1 (de) Hautreinigungsmittel
DE602004021365D1 (de) Substituierte phenylacetamide und ihre anwendung als protease inhibitoren
FI20041220A0 (fi) Uusi lakkaasientsyymi ja sen käyttö
BRPI0719997A2 (pt) Uso de epotilonas no tratamento de osteoporose e doenças relacionadas
EP1668464A4 (fr) Utilisation d'une technologie de transformation pour elaborer des descriptions semantiques
FR2879924B1 (fr) Composition cosmetique amincissante
JP2003119489A5 (ja) 香料成分としての第三アルコールまたはエステルの使用
ITMI20041962A1 (it) "peptide di angiostatina e suoi impieghio terapeutici"
FR2876912B1 (fr) Nouvelle utilisation de guggulipides en therapeutique et en cosmetique
ITMI20052482A1 (it) Formulazioni cosmetiche e dermatologiche comprendenti filtri solari

Legal Events

Date Code Title Description
TP Transmission of property
TP Transmission of property
PLFP Fee payment

Year of fee payment: 12

ST Notification of lapse

Effective date: 20170131